Correction for Morozko et al., PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington’s disease

NEUROSCIENCE Correction for “PIAS1 modulates striatal transcription, DNA harm repair service and SUMOylation relevant to Huntington’s ailment”, by Eva L. Morozko, Charlene Smith-Geater, Alejandro Mas Monteys, Subrata Pradhan, Ryan G. Lim, Peter Langfelder, Marketta Kachemov , Austin Hill, Jennifer T. Stocksdale, Pieter R. Cullis, Jie Wu, Joseph Ochaba, Ricardo Miramontes, Anirban Chakraborty, Tapas K. Hazra, Alice Lau, Sophie St-cyr, Iliana Orellana, Lexi Kopan, Keona Q. Wang, Sylvia Yeung, Blair R. Leavitt, Jack C. Reidling, X. William Yang, Joan S. Steffan, Beverly L. Davidson, Partha S. Sarkar, and Leslie M. Thompson, posted January 19, 2021 10.1073 / pnas.2021836118 (Proc. Natl. Acad. Sci. United states of america 118, e2021836118).

The authors suggest that Jayesh A. Kulkarni and Josh Zaifman really should be extra to the listing of authors amongst Marketta Kachemov and Austin Hill. Jayesh A. Kulkarni ought to be credited with Contributing New Reagents / Analytical Instruments and Investigation Carried out. Josh Zaifman really should be credited with contributions to new reagents / analytical tools and investigation carried out. The corrected creator line, affiliation line and author contributions are revealed down below. The on the net edition has been corrected.

Eva L. Morozkoon, Charlene Smith-GeaterB., Alejandro Mas MonteysC., Subrata PradhanD., Ryan G. Lime, Peter LangfelderF., Marketta Kachemovon, Jayesh A. KulkarniG, Josh ZaifmanH, Austin HillI, Jennifer T. Stocksdaleon, Pieter R. Cullisg, j, Jie Wuk, Joseph Ochabaon, Ricardo Miramontese, Anirban Chakrabortyl, Tapas K. Hazral, Alice LauB., Sophie St-cyrC., Iliana Orellanam, Lexi KopanB., Keona Q. WangB., Sylvia Yeunge, Blair R. Leavittn, Jack C. Reidlinge, X. William YangÖ, Joan S. Steffangetting, Beverly L. Davidsonc, p, Partha S. Sarkard, q, and Leslie M. Thompsona, b, e, k, m

a Office of Neurobiology and Conduct, University of California, Irvine, CA 92697 b Office of Psychiatry and Human Conduct, University of California, Irvine, CA 92697 cRaymond G. Perelman Middle for Cell and Molecular Therapeutics, The Kid’s Medical center of Philadelphia, Philadelphia, PA 19104 d Department of Neurology, University of Texas Clinical Division, Galveston, TX 77555 eInstitute of Memory Impairments and Neurological Ailments, University of California, Irvine, CA 92697 f Office of Human Genetics, David Geffen College of Medication at the College of California, Los Angeles, CA 90095 gDepartment of Biochemistry and Molecular Biology, College of British Columbia, Vancouver, BC, Canada V6T 1Z3 hDepartment of Chemistry, University of British Columbia, Vancouver, BC, Canada V6T 1Z1 iIncisive Genetics Inc., Vancouver, BC, Canada V6A 0H9 jNanoMedicines Innovation Network, College of British Columbia, Vancouver, BC, Canada V6T 1Z3 k Division of Organic Chemistry, College of California, Irvine, CA 92697 l Office of Inner Drugs, Health care Department of the College of Texas, Galveston, TX 77555 mSue and Invoice Gross Stem Cell Institute, College of California, Irvine, CA 92697 nCentre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada V5Z 4H4 o Centre for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Habits, College of California, Los Angeles, CA 90095 p Office of Pathology and Laboratory Medication, University of Pennsylvania, Philadelphia, PA 19104 and qDepartment of Neuroscience and Mobile Biology, College of Texas Professional medical Branch, Galveston, TX 77555

Authors’ contributions: ELM, CS-G., AMM, BRL, JCR, BLD, PSS and LMT developed investigation ELM, CS-G., AMM, SP, MK, JAK, JZ, AH, JTS, PRC, JO, AC, TKH, AL, SS-c., IO, LK, KQW and SY performed investigate JAK and JZ contributed new reagents / evaluation tools ELM, CS-G., SP, RGL, PL, JW, RM, JCR, XWY and JSS analyzed information ELM, CS-G., JCR, XWY, JSS and LMT authored the paper and BLD, PSS and LMT delivered sources and funding.